Table: Fuji Pharmaceutical -2016/17 group results

Fuji Pharma

10/11/2017 07:30

Nov 10 (Reuters)-  
          Fuji Pharmaceutical  Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Sep 30, 2017    Sep 30, 2016   Sep 30, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           35.39           34.23          38.14        19.13     
               (+3.4 pct)      (+8.0 pct)     (+7.8 pct)   (+10.4 pct)  
  Operating        4.31            3.57           4.85         2.63     
               (+20.9 pct)     (+9.7 pct)     (+12.4 pct)  (+15.6 pct)  
  Recurring        4.63            3.25           4.71         2.58     
               (+42.3 pct)     (+4.9 pct)     (+1.8 pct)    (+1.7 pct)  
  Net 
  Net              3.30            2.12           3.35         1.84     
               (+55.8 pct)     (+1.2 pct)     (+1.3 pct)    (+2.5 pct)  
  EPS          220.63 yen      141.64 yen     223.53 yen    122.62 yen  
  Ann Div       48.00 yen       45.00 yen      56.00 yen                
  -Q2 Div       23.00 yen       21.00 yen      28.00 yen                
  -Q4 Div       25.00 yen       24.00 yen      28.00 yen                
   
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T 
  ((Tokyo Headline News Desk +813 6441 1812))